Hormone replacement therapy: Key market research findings
- Technological advancements in drug delivery systems
- Rise in estrogen replacement therapies
Technavio has added a new market research report on the global hormone replacement therapy market, to its therapeutics portfolio. Technavio’s market analysts estimate the global hormone replacement therapy market to grow at a CAGR of more than 2% between 2015 and 2019. In recent years, there has been an increase in hormone replacement therapies due to an increase in the patients experiencing menopause, and those with a deficiency of growth hormones. The Americas dominate ten global market for hormone replacement therapies, accounting for 51% of the total market share. High purchasing power of patients and growing awareness are expected to contribute to the dominance of the American market during the forecast period.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“Of late, new drug delivery systems such as transdermal drug delivery have gained prominence in the market. The main advantage of transdermal administration is that the drugs bypass the first-pass metabolism, and the drug diffuses passively across the skin. These delivery systems propel controlled release of medication into the circulatory system. The market is expected to witness several advancements in the experimental drug delivery systems including those composed of polymers, dendrimers, and electroactive polymers,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Estrogen replacement therapies account for around 60% of the total hormone replacement therapy market. This therapy is most commonly used to prevent postmenopausal osteoporosis and helps in the reduction of short-term changes of menopause such as hot flashes, disturbed sleep, and vaginal dryness. Premarin and Prempro are the major drugs used in estrogen replacement therapy.
The key vendors in the global hormone replacement therapy market includes F. Hoffmann-La Roche, Merck Serono, Novartis, Novo Nordisk, and Pfizer. The market is a mature market, which is extremely competitive due to the presence of a huge number of small and large vendors. Therefore, development of low-dose oral drugs and locally acting transdermal hormonal replacement products with high efficacy is expected to captivate the attention of players in the hormonal replacement market.
A more detailed analysis is available in the Technavio report, Global Hormone Replacement Therapy Market 2015-2019.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
- Human Growth Hormone Market in the US 2015-2019
- Global Hyperbaric Oxygen Therapy Devices Market: Industry Analysis 2015-2019
- Global Cardiac Resynchronization Therapy (CRT) Devices Market 2015-2019
- Global Human Growth Hormone Market 2015-2019
- Global Heart Valve Repair and Replacement Market 2014-2018
Further Reading:
